Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:06 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | VANGUARD GROUP INC | 19,766,042 7.24% | 2,723,542 (+15.98%) | View |
| 2024-01-22 10:20 am Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 871,047 0.32% | -6,400 (-0.73%) | View |
| 2023-07-10 2:07 pm Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 877,447 0.33% | -30,594,905 (-97.21%) | View |
| 2023-07-07 4:35 pm Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | BlackRock Inc. BLK | 6,086,623 2.3% | -17,197,496 (-73.86%) | View |
| 2023-02-09 3:11 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 31,472,352 12.61% | 8,204,424 (+35.26%) | View |
| 2023-02-09 11:22 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | VANGUARD GROUP INC | 17,042,500 6.83% | 6,003,187 (+54.38%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | BlackRock Inc. BLK | 23,284,119 9.3% | 5,039,205 (+27.62%) | View |
| 2022-04-11 2:07 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 23,267,928 10.49% | 9,967,498 (+74.94%) | View |
| 2022-02-11 11:41 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 13,300,430 6.32% | 4,405,875 (+49.53%) | View |
| 2022-02-10 08:17 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | VANGUARD GROUP INC | 11,039,313 5.25% | 1,853,674 (+20.18%) | View |
| 2022-02-01 5:08 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | BlackRock Inc. BLK | 18,244,914 8.7% | 4,001,973 (+28.10%) | View |
| 2021-02-11 4:03 pm Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | Nikko Asset Management Americas Inc. | 0 0% | -5,047,608 (Position Closed) | View |
| 2021-02-11 2:42 pm Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | WASATCH ADVISORS LP | 3,939,018 2.3% | -3,543,809 (-47.36%) | View |
| 2021-02-10 11:04 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | VANGUARD GROUP INC | 9,185,639 5.42% | 4,133,245 (+81.81%) | View |
| 2021-02-10 08:52 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | STATE STREET CORP STT | 8,894,555 5.25% | 8,894,555 (New Position) | View |
| 2021-02-05 06:10 am Sale | 13G | INOVIO PHARMACEUTICALS, INC. N INO | Sumitomo Mitsui Trust Holdings Inc. | 0 0% | -5,047,608 (Position Closed) | View |
| 2021-01-29 09:57 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | BlackRock Inc. BLK | 14,242,941 8.4% | 6,608,341 (+86.56%) | View |
| 2020-02-12 5:09 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | Nikko Asset Management Americas Inc. | 5,047,608 5.05% | 5,047,608 (New Position) | View |
| 2020-02-12 06:02 am Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | Sumitomo Mitsui Trust Holdings Inc. | 5,047,608 5.05% | 5,047,608 (New Position) | View |
| 2020-02-11 4:44 pm Purchase | 13G | INOVIO PHARMACEUTICALS, INC. N INO | VANGUARD GROUP INC | 5,052,394 5.05% | 5,052,394 (New Position) | View |